Shree Ganesh Remedies Ltd. – Company Report
1. Company Overview
Shree Ganesh Remedies Ltd. (SGRL), established in 1995 and headquartered in Ankleshwar, Gujarat, is a prominent Indian manufacturer specializing in pharmaceutical drug intermediates, fine chemicals, and specialty chemicals. Part of the Ganesh Group, the company has carved a niche in supplying high-quality chemical solutions to both domestic and international pharmaceutical and allied industries.
SGRL is ISO 9001:2015, ISO 14001:2015, and OHSAS 18001:2007 certified, with a DSIR-recognized R&D lab, reflecting its commitment to stringent quality and management standards. Its advanced manufacturing infrastructure includes three facilities spread over 9,715 sq. meters, comprising over 10 production blocks, all operating under Total Quality Management practices. Since exporting began in 2006, the company has steadily grown its global footprint. SGRL remains a family-run enterprise, led by Chairman and Managing Director Chandu C. Kothia.
- Incorporated: 1995
- Headquarters: Ankleshwar, Gujarat, India
- Certifications: ISO 9001:2015, ISO 14001:2015, OHSAS 18001:2007, DSIR-recognized R&D lab
- Core Focus: Pharmaceutical intermediates, fine & specialty chemicals, bulk drugs
- Manufacturing Plants: Three facilities in Ankleshwar with 10+ production blocks
- Leadership: Chairman & MD – Chandu C. Kothia
- Employees: 100–249
- Listed on: BSE (540737); Market Cap (Aug 2025): ~₹740 crore (recent price: ~₹575)
- Global Presence: Exports to multiple countries since 2006
2. Products and Services
Shree Ganesh Remedies Ltd. provides a wide portfolio of high-value chemical products and solutions across pharmaceutical and allied sectors.
Pharmaceutical Drug Intermediates & Fine Chemicals
- Supplies intermediates for APIs related to antipsychotic, antiseptic, anti-viral, Alzheimer’s, and hyperlipidemia treatments.
- Key products: Diphenylacetonitrile, Diethylaminoethyl Chloride, Trityl Chloride, Amine Hydrochlorides, Chloroethyl Morpholine Hydrochloride.
Custom Chemical Synthesis & Contract Manufacturing
- Offers CRAMS for specialty intermediates and custom molecules.
- Specializes in chlorination and reduction reaction technologies.
Research & Development
- DSIR-recognized lab focused on new molecule development and process innovation.
- Expertise in technology transfer and continuous product development.
Industries Served
- Pharmaceuticals (primary), Polymers, Agrochemicals, Electronics, Aroma, and Industrial Chemicals.
Value-Added Services
- Custom manufacturing, technical documentation, global regulatory support, and strategic collaborations.
3. Recent News and Financial Performance
Business Developments
- Shree Ganesh Remedies Limited received a GST summons from the Superintendent of Central GST and Central Excise Unit, Vadodara, alleging violations related to expired stock in a company warehouse. The summons involves a potential GST liability of approximately Rs. 88.61 Lacs.
Expansion and Investment
- In December 2022, the company announced a ₹60 crore Capex plan over two years for capacity upgrades and new technology in chemical reactions.
- Acquisition of Jaiswal PharmaChem’s plant and land is aimed at scaling specialty chemical and CRAMS operations.
Sustainability Initiatives
- In July 2025, SGRL commissioned a 2 MW solar power plant with auto-tracker modules. This initiative is expected to save ₹2 crore annually in electricity costs.
Strategic Partnerships
- In January 2025, SGRL signed a three-year MOU (with a potential two-year extension) with a leading Japanese company for three innovative chemical products, enhancing its CRAMS capabilities for the international market.
4. Financial Performance (FY2025)
| Metric | FY2025 Value |
|---|---|
| Total Income | ₹113 crore |
| Net Profit (PAT) | ₹23.10 crore |
| EPS | ₹18 |
| Operating Profit Margin | ~36% |
| PAT Margin | ~20% |